Discover
CRL
Charles River Laboratories International, Inc.
219.40
1 x 216.11
1 x 223.68
bid
ask
-
0.30
0.14%
1 @ 04:00 PM
217.10 -2.30 (1.05%)
| Ytd | 9.99% | |
| 1y | 46.47% |
213.40
day range
223.62
144.26
52 week range
237.86
| Open | 215.57 | Prev Close | 219.70 | Low | 213.40 | High | 223.62 | Mkt Cap | 10.57B |
| Vol | 925.04K | Avg Vol | 891.60K | EPS | 10.00 | P/E | 21.94 | Forward P/E | 20.16 |
| Beta | 1.40 | Short Ratio | 5.13 | Inst. Own | 123.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 193.50 | 200-d Avg | 184.91 | 1yr Est | 230.93 |
| Income Statement | |||
| Total Revenue | 995.83M | ||
| Revenues (USD) | 995.83M | ||
| Cost of Revenue | 701.17M | ||
| Gross Profit | 294.66M | ||
| Operating Expenses | 174.77M | ||
| Selling, General and Administrative Expense | 159.42M | ||
| Operating Income | 119.90M | ||
| Interest Expense | 26.74M | ||
| Income Tax Expense | -15.14M | ||
| Net Income | -14.84M | ||
| Net Income Common Stock | -14.84M | ||
| Net Income Common Stock (USD) | -14.84M | ||
| Consolidated Income | -14.80M | ||
| Net Income to Non-Controlling Interests | 41.00K | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -3.24M | ||
| Earning Before Interest & Taxes (USD) | -3.24M | ||
| Weighted Average Shares | 48.95M | ||
| Weighted Average Shares Diluted | 48.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 191.83M | ||
| Cash and Equivalents (USD) | 191.83M | ||
| Investments | 209.72M | ||
| Investments Non-Current | 209.72M | ||
| Trade and Non-Trade Receivables | 700.25M | ||
| Current Assets | 1.49B | ||
| Property, Plant & Equipment Net | 1.83B | ||
| Total Assets | 7.73B | ||
| Total Debt | 3.06B | ||
| Current Liabilities | 1.09B | ||
| Debt Non-Current | 3.06B | ||
| Total Liabilities | 4.74B | ||
| Accumulated Retained Earnings (Deficit) | 1.37B | ||
| Accumulated Other Comprehensive Income | -191.04M | ||
| Shareholders Equity | 2.94B | ||
| Shareholders Equity (USD) | 2.94B | ||
| Assets Non-Current | 6.24B | ||
| Total Debt (USD) | 3.06B | ||
| Deferred Revenue | 194.33M | ||
| Goodwill and Intangible Assets | 3.29B | ||
| Inventory | 359.72M | ||
| Liabilities Non-Current | 3.65B | ||
| Trade and Non-Trade Payables | 133.95M | ||
| Tax Assets | 88.60M | ||
| Tax Liabilities | 81.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 67.15M | ||
| Net Cash Flow from Financing | 347.72M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.80M | ||
| Capital Expenditure | -55.91M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -353.40M | ||
| Issuance (Purchase) of Equity Shares | -207.06M | ||
| Issuance (Repayment) of Debt Securities | 556.79M | ||
| Net Cash Flow from Investing | -407.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.92M | ||
| Net Cash Flow from Operations | 41.08M | ||
| Effect of Exchange Rate Changes on Cash | 1.25M | ||
| Share Based Compensation | 22.38M | ||